产品: SLC27A5 抗体
货号: DF3845
描述: Rabbit polyclonal antibody to SLC27A5
应用: WB IHC IF/ICC
文献验证: WB
反应: Human, Mouse, Rat
预测: Bovine, Horse
蛋白号: Q9Y2P5
RRID: AB_2836202

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:1000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
SLC27A5 Antibody detects endogenous levels of total SLC27A5.
RRID:
AB_2836202
引用格式: Affinity Biosciences Cat# DF3845, RRID:AB_2836202.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

ACSB; ACSVL6; BA CoA ligase; BA-CoA ligase; BACS; BAL; Bile acid CoA ligase; Bile acid-CoA ligase; Bile acyl CoA synthetase; Bile acyl-CoA synthetase; Cholate CoA ligase; Cholate--CoA ligase; FACVL3; FATP 5; FATP-5; FATP5; Fatty acid Coenzyme A ligase very long chain 3; Fatty acid transport protein 5; Fatty-acid-coenzyme A ligase; FLJ22987; S27A5_HUMAN; Slc27a5; Solute carrier family 27 (fatty acid transporter) member 5; Solute carrier family 27 member 5; Very long chain acyl CoA synthetase homolog 2; Very long chain acyl CoA synthetase related protein; very long-chain 3; Very long-chain acyl-CoA synthetase homolog 2; Very long-chain acyl-CoA synthetase-related protein; VLACS related; VLACS-related; VLACSR; VLCS H2; VLCS-H2; VLCSH2;

抗原和靶标

免疫原:

A synthesized peptide derived from human SLC27A5, corresponding to a region within the internal amino acids.

基因/基因ID:

研究领域

· Human Diseases > Endocrine and metabolic diseases > Insulin resistance.

· Metabolism > Lipid metabolism > Primary bile acid biosynthesis.

· Metabolism > Global and overview maps > Metabolic pathways.

· Organismal Systems > Endocrine system > PPAR signaling pathway.

文献引用

1). B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36. Cell death & disease, 2022 (PubMed: 35436984) [IF=8.1]

Application: WB    Species: Mouse    Sample:

Fig. 5: Overexpression of BCL6 hampers CD36 expression both in vivo and in vitro. Relative mRNA levels of genes related to (A) FFA oxidation, (B) synthesis, and (C) uptake in the livers of AAV-Control mice and the AAV-BCL6 mice fed an HFD for 16 weeks. D Protein level of BCL6 and genes related to FFA uptake in the livers of mice. Relative mRNA levels of gene related to (E) FFA oxidation, (F) synthesis and G uptake in the livers of AAV-Control mice and the AAV-BCL6 mice fed an HFD for 16 weeks. D Protein level of BCL6 and genes related to FFA uptake in the livers of mice. Relative mRNA levels of gene related to (E) FFA oxidation, (F) synthesis, and (G) uptake in the LO2 cells stimulated with PA (0.3 mM) for 24 h after transfected with Ad-GFP or Ad-BCL6 for 48 h. n = 3 in each group. H Protein level of BCL6 and genes related to FFA uptake in the LO2 cells. Data represent the mean ± SEM, *P 

2). Norepinephrine inhibits CD8+ T-cell infiltration and function, inducing anti-PD-1 mAb resistance in lung adenocarcinoma. British journal of cancer, 2023 (PubMed: 36646807) [IF=6.4]

Application: WB    Species: human    Sample: LUAD cells

Fig. 5: Norepinephrine (NE) regulates the secretion of CXCL9 and adenosine (ADO) by WNT7A/β-catenin signalling in lung adenocarcinoma (LUAD) cells. a The KEGG pathway enrichment analysis of the differentially expressed genes (DEGs); b the GSEA between the NE and the control (NC) groups; c the volcano plots of the DEGs; d the expression levels of Wnt1, Wnt2, Wnt3a, Wnt4, Wnt5a, Wnt6, Wnt7a and Wnt10a in the tumour tissues of the anti-PD-1 mAb + Vehicle and NE + anti-PD-1 mAb + Vehicle groups; e western blotting confirmed the efficiency of WNT7A silencing; f downregulation of WNT7A by shRNA significantly antagonised NE-induced β-catenin, CD39 and CD73 expression, as well as NE-inhibited CXCL9 expression in LUAD cells; g downregulation of β-catenin by shRNA greatly antagonised NE/WNT7A-induced CD39 and CD73 expression, as well as NE/WNT7A-inhibited CXCL9 expression in LUAD cells; h the β-catenin expression level in tumours was detected in the anti-PD-1 mAb + vehicle group and anti-PD-1 mAb+NE + vehicle group using immunohistochemistry. *P 

3). Over-Expression and Prognostic Significance of FATP5, as a New Biomarker, in Colorectal Carcinoma. Frontiers in Molecular Biosciences, 2022 (PubMed: 35155561) [IF=5.0]

4). Identification of key genes associated with the progression of liver fibrosis to hepatocellular carcinoma based on iTRAQ proteomics and GEO database. Annals of hepatology, 2022 (PubMed: 35124283) [IF=3.7]

Application: WB    Species: human    Sample:

Fig. 8. The expression and survival analysis of ALDH2, SLC27A5 and ASNS in patients with HCC and validation. (A) The expression of ALDH2, SLC27A5 and ASNS in HCC. (B) The expression of ALDH2, SLC27A5 and ASNS in different stages of HCC. (C) Survival analysis of ALDH2, SLC27A5 and ASNS. (D) WB analysis of ALDH2, SLC27A5 and ASNS. (E) qRT-PCR analysis of ALDH2, SLC27A5 and ASNS.

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.